BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 36172137)

  • 1. Omicron Subvariants: Clinical, Laboratory, and Cell Culture Characterization.
    Morris CP; Eldesouki RE; Sachithanandham J; Fall A; Norton JM; Abdullah O; Gallagher N; Li M; Pekosz A; Klein EY; Mostafa HH
    medRxiv; 2022 Sep; ():. PubMed ID: 36172137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omicron Subvariants: Clinical, Laboratory, and Cell Culture Characterization.
    Morris CP; Eldesouki RE; Sachithanandham J; Fall A; Norton JM; Abdullah O; Gallagher N; Li M; Pekosz A; Klein EY; Mostafa HH
    Clin Infect Dis; 2023 Apr; 76(7):1276-1284. PubMed ID: 36366857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Quick Displacement of the SARS-CoV-2 variant Delta with Omicron: Unprecedented Spike in COVID-19 Cases Associated with Fewer Admissions and Comparable Upper Respiratory Viral Loads.
    Fall A; Eldesouki RE; Sachithanandham J; Morris CP; Norton JM; Gaston DC; Forman M; Abdullah O; Gallagher N; Li M; Swanson NJ; Pekosz A; Klein EY; Mostafa HH
    medRxiv; 2022 Jan; ():. PubMed ID: 35118480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The displacement of the SARS-CoV-2 variant Delta with Omicron: An investigation of hospital admissions and upper respiratory viral loads.
    Fall A; Eldesouki RE; Sachithanandham J; Morris CP; Norton JM; Gaston DC; Forman M; Abdullah O; Gallagher N; Li M; Swanson NJ; Pekosz A; Klein EY; Mostafa HH
    EBioMedicine; 2022 May; 79():104008. PubMed ID: 35460989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infection with the SARS-CoV-2 Delta Variant is Associated with Higher Infectious Virus Loads Compared to the Alpha Variant in both Unvaccinated and Vaccinated Individuals.
    Luo CH; Morris CP; Sachithanandham J; Amadi A; Gaston D; Li M; Swanson NJ; Schwartz M; Klein EY; Pekosz A; Mostafa HH
    medRxiv; 2021 Aug; ():. PubMed ID: 34462756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Characterization of AZD7442 (Tixagevimab-Cilgavimab) Neutralization of SARS-CoV-2 Omicron Subvariants.
    Roe TL; Brady T; Schuko N; Nguyen A; Beloor J; Guest JD; Aksyuk AA; Tuffy KM; Zhang T; Streicher K; Kelly EJ; Kijak GH
    Microbiol Spectr; 2023 Mar; 11(2):e0033323. PubMed ID: 36877050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Automated antigen assays display a high heterogeneity for the detection of SARS-CoV-2 variants of concern, including several Omicron sublineages.
    Osterman A; Krenn F; Iglhaut M; Badell I; Lehner A; Späth PM; Stern M; Both H; Bender S; Muenchhoff M; Graf A; Krebs S; Blum H; Grimmer T; Durner J; Czibere L; Dächert C; Grzimek-Koschewa N; Protzer U; Kaderali L; Baldauf HM; Keppler OT
    Med Microbiol Immunol; 2023 Oct; 212(5):307-322. PubMed ID: 37561226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the replication and neutralization of different SARS-CoV-2 Omicron subvariants in vitro.
    Zhang Y; Lv Q; Qi F; Li F; Deng R; Liang X; Liu M; Yan Y; Bao L
    Animal Model Exp Med; 2023 Feb; 6(1):51-56. PubMed ID: 36808904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of clinical and immunological profiles across Omicron BA.5.2 subvariants using next-generation sequencing in a Chinese cohort.
    Huang J; Xia M; Liu R; Wang S; Duan X; Peng J; Li E; Zhou Y; Li C; Zhang Q; Tian J; Wang X; Su Z; Tan J; Peng B; Zhang J; Li J; Dai L; Lei M
    Front Cell Infect Microbiol; 2023; 13():1288914. PubMed ID: 37965255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutralization sensitivity, fusogenicity, and infectivity of Omicron subvariants.
    Wang XJ; Yao L; Zhang HY; Zhu KL; Zhao J; Zhan BD; Li YK; He XJ; Huang C; Wang ZY; Jiang MD; Yang P; Yang Y; Wang GL; Wang SQ; Dai EH; Gao HX; Ma MJ
    Genome Med; 2022 Dec; 14(1):146. PubMed ID: 36581867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Clinical Outcomes and Imaging Features in Hospitalized Patients with SARS-CoV-2 Omicron Subvariants.
    Lee JE; Hwang M; Kim YH; Chung MJ; Jeong WG; Sim BH; Jeong YJ
    Radiology; 2023 Jul; 308(1):e230653. PubMed ID: 37462497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ten rapid antigen tests for SARS-CoV-2 widely differ in their ability to detect Omicron-BA.4 and -BA.5.
    Krenn F; Dächert C; Badell I; Lupoli G; Öztan GN; Feng T; Schneider N; Huber M; Both H; Späth PM; Muenchhoff M; Graf A; Krebs S; Blum H; Durner J; Czibere L; Kaderali L; Keppler OT; Baldauf HM; Osterman A
    Med Microbiol Immunol; 2023 Oct; 212(5):323-337. PubMed ID: 37561225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 Omicron subvariants exhibit distinct fusogenicity, but similar sensitivity, to pan-CoV fusion inhibitors.
    Xia S; Wang L; Jiao F; Yu X; Xu W; Huang Z; Li X; Wang Q; Zhu Y; Man Q; Jiang S; Lu L
    Emerg Microbes Infect; 2023 Dec; 12(1):2178241. PubMed ID: 36748716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variable detection of Omicron-BA.1 and -BA.2 by SARS-CoV-2 rapid antigen tests.
    Osterman A; Badell I; Dächert C; Schneider N; Kaufmann AY; Öztan GN; Huber M; Späth PM; Stern M; Autenrieth H; Muenchhoff M; Graf A; Krebs S; Blum H; Czibere L; Durner J; Kaderali L; Baldauf HM; Keppler OT
    Med Microbiol Immunol; 2023 Feb; 212(1):13-23. PubMed ID: 36370197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical severity of Omicron subvariants BA.1, BA.2, and BA.5 in a population-based cohort study in British Columbia, Canada.
    Russell SL; Klaver BRA; Harrigan SP; Kamelian K; Tyson J; Hoang L; Taylor M; Sander B; Mishra S; Prystajecky N; Janjua NZ; Zlosnik JEA; Sbihi H
    J Med Virol; 2023 Jan; 95(1):e28423. PubMed ID: 36546412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omicron (B.1.1.529) variant and its subvariants and lineages may lead to another COVID-19 wave in the world? -An overview of current evidence and counteracting strategies.
    Sah R; Rais MA; Mohanty A; Chopra H; Chandran D; Bin Emran T; Dhama K
    Int J Surg Open; 2023 Jun; 55():100625. PubMed ID: 37255735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune Evasion of SARS-CoV-2 Omicron Subvariants.
    Ke H; Chang MR; Marasco WA
    Vaccines (Basel); 2022 Sep; 10(9):. PubMed ID: 36146623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surveillance and Analysis of SARS-CoV-2 Variant Importation - China, January-June 2022.
    Feng Y; Zhao X; Yin Z; Wu C; Chen Z; Nie K; A R; Li L; Niu P; Wang J; Wu Y; Wang S; Wang D; Tan W; Wang H; Ma X; Gao GF; Chen C; Xu W
    China CDC Wkly; 2022 Dec; 4(50):1136-1142. PubMed ID: 36751558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unique mutations in SARS-CoV-2 Omicron subvariants' non-spike proteins: Potential impacts on viral pathogenesis and host immune evasion.
    Hossain A; Akter S; Rashid AA; Khair S; Alam ASMRU
    Microb Pathog; 2022 Sep; 170():105699. PubMed ID: 35944840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced neutralization resistance of SARS-CoV-2 Omicron subvariants BQ.1, BQ.1.1, BA.4.6, BF.7, and BA.2.75.2.
    Qu P; Evans JP; Faraone JN; Zheng YM; Carlin C; Anghelina M; Stevens P; Fernandez S; Jones D; Lozanski G; Panchal A; Saif LJ; Oltz EM; Xu K; Gumina RJ; Liu SL
    Cell Host Microbe; 2023 Jan; 31(1):9-17.e3. PubMed ID: 36476380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.